Evidence map›Paper›PMID 34095634›Full record

ArticleJACC. Basic to translational science2021

Can a Biohybrid Patch Salvage Ventricular Function at a Late Time Point in the Post-Infarction Remodeling Process?

Lindemberg M Silveira-Filho, Garrett N Coyan, Arianna Adamo, Samuel K Luketich, Giorgio Menallo, Antonio D'Amore, William R Wagner

Open access · goldAbstract read
In one paragraph

Article in JACC. Basic to translational science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. PECUU-ECM Patches: The Future of Ischemic Heart Disease Repair.JACC. Basic to translational science · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Lindemberg M Silveira-FilhoMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Garrett N CoyanMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Arianna AdamoMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Samuel K LuketichMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Giorgio MenalloMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Antonio D'AmoreMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
William R WagnerMcGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
McGowan Institute for Regenerative Medicine · USUniversity of Pittsburgh · USUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A biohybrid patch without cellular components was implanted over large infarcted areas in severely dilated hearts. Nonpatched animals were assigned to control or losartan therapy. Patch-implanted animals responded with better morphological and functional echocardiographic endpoints, which were more evident in a subgroup of animals with very low pre-treatment ejection fraction (<35%). Patched animals also had smaller infarcts than both nonpatched groups. This simple approach could hold promise for clinical translation and be applied using minimally invasive procedures over the epicardium in a large set of patients to induce better ventricular remodeling, especially among those who are especially frail.

Indexed as

AT1R, angiotensin 1 receptorbiomaterialcardiac patchECM, extracellular matrixEDA, end-diastolic areaEF, ejection fractionESA, end-systolic areaFS, fractional shorteningHF, heart failureleft ventricular remodelingLVdd, left ventricular end-diastolic diameterLVEF, left ventricular ejection fractionLVFW, left ventricular free wallLV, left ventricleLVsd, left ventricular end-systolic diameterM1, macrophage type 1M2, macrophage type 2MI, myocardial infarctionMT, Masson trichromemyocardial infarctionPBS, phosphate-buffered salinePECUU, poly(ester carbonate urethane) ureaPEUU, poly(ester urethane) ureaSMA, smooth muscle actin

Identifiers

PMID34095634
PMCPMC8165254
OpenAlexW3137181481

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.